An Objectives, Indications, Mechanism of Action, Pharmacokinetics, Administration, Adverse Effects, Drug-Drug Interactions, Contra Indication, Toxicity and Health Care Team Outcomes of Enalapril Drug

One well-known angiotensin-converting enzyme inhibitor that has been approved by the US Food and Drug Administration (FDA) for the treatment of asymptomatic left ventricular dysfunction, persistent hypertension, and heart failure is enalapril maleate. A fixed-dose combination of hydrochlorothiazide and enalapril has been approved by the FDA. Because it reduces mortality and slows the progression to symptomatic heart failure, enalapril is used to treat asymptomatic left ventricular dysfunction. This activity provides information on enalapril's indications, mechanism of action, adverse event profile, dosage considerations, monitoring techniques, and possible drug interactions. It highlights the medication's crucial role as an effective treatment for hypertension and related conditions. This exercise also emphasizes the value of an interprofessional healthcare team working together to effectively use and manage enalapril, guaranteeing shared decision-making and patient safety while providing patients with hypertension and associated conditions with the best care possible.